Evidence map›Paper›PMID 25580147›Full record

ArticleDrug discovery today. Therapeutic strategies2013

Natural antisense transcripts as therapeutic targets.

Paul Halley, Olga Khorkova, Claes Wahlestedt

Abstract read
In one paragraph

Article in Drug discovery today. Therapeutic strategies, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Antisense lncRNAFrontiers in molecular biosciences · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Natural antisense transcripts.Human molecular genetics · 2014
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Paul HalleyDepartment of Psychiatry and Behavioral Sciences, and Center for Therapeutic Innovation, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Olga KhorkovaOPKO-CURNA 10320 USA Today Way, Miramar, FL 33025, USA.
Claes WahlestedtDepartment of Psychiatry and Behavioral Sciences, and Center for Therapeutic Innovation, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

Funding

Comprehensive analysis of the FMR1 locus transcriptional landscapeR01MH084880 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI WAHLESTEDT, CLAES ROBERT · 2010 to 2014
$2.0M
Role of noncoding RNAs in schizophreniaR01MH083733 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI WAHLESTEDT, CLAES ROBERT · 2008 to 2012
$2.0M
Regulatory RNAs as mediators and biomarkers in Alzheimer's DiseaseR01NS063974 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI WAHLESTEDT, CLAES ROBERT · 2009 to 2012
$1.6M
Noncoding RNAs as epigenomic modulators in Alzheimer's DiseaseRC2AG036596 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI WAHLESTEDT, CLAES ROBERT · 2009 to 2010
$915k
RNAi strategy for prolonged inhibition of BACE1: Role for noncoding RNAR21AG029290 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI WAHLESTEDT, CLAES ROBERT · 2007 to 2008
$401k
NIA NIH HHS R21 AG029290NIA NIH HHS RC2 AG036596NIMH NIH HHS R01 MH083733NIMH NIH HHS R01 MH084880NINDS NIH HHS R01 NS063974
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID25580147
PMCPMC4286396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.